nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinnarizine—CYP1A1—Clobetasol propionate—psoriasis	0.18	0.202	CbGbCtD
Cinnarizine—CYP2A6—Methoxsalen—psoriasis	0.111	0.124	CbGbCtD
Cinnarizine—CYP1A1—Methoxsalen—psoriasis	0.0947	0.106	CbGbCtD
Cinnarizine—CYP1A2—Clobetasol propionate—psoriasis	0.0805	0.0903	CbGbCtD
Cinnarizine—CYP1A1—Cholecalciferol—psoriasis	0.0627	0.0703	CbGbCtD
Cinnarizine—CYP2A6—Prednisolone—psoriasis	0.0539	0.0604	CbGbCtD
Cinnarizine—CYP2B6—Cholecalciferol—psoriasis	0.0478	0.0536	CbGbCtD
Cinnarizine—CYP1A2—Methoxsalen—psoriasis	0.0423	0.0474	CbGbCtD
Cinnarizine—CYP2D6—Hydroxyurea—psoriasis	0.0381	0.0427	CbGbCtD
Cinnarizine—CYP2A6—Dexamethasone—psoriasis	0.0318	0.0356	CbGbCtD
Cinnarizine—CACNA1S—pes—psoriasis	0.0276	0.818	CbGeAlD
Cinnarizine—CYP1A1—Dexamethasone—psoriasis	0.0271	0.0304	CbGbCtD
Cinnarizine—CYP2C9—Cholecalciferol—psoriasis	0.0253	0.0283	CbGbCtD
Cinnarizine—CYP2D6—Cholecalciferol—psoriasis	0.0231	0.0259	CbGbCtD
Cinnarizine—CYP2B6—Dexamethasone—psoriasis	0.0207	0.0232	CbGbCtD
Cinnarizine—CYP2C9—Cyclosporine—psoriasis	0.0166	0.0186	CbGbCtD
Cinnarizine—CYP2D6—Cyclosporine—psoriasis	0.0152	0.017	CbGbCtD
Cinnarizine—CYP2C9—Dexamethasone—psoriasis	0.0109	0.0123	CbGbCtD
Cinnarizine—CYP2D6—Dexamethasone—psoriasis	0.00999	0.0112	CbGbCtD
Cinnarizine—CYP1A1—skin epidermis—psoriasis	0.00219	0.0649	CbGeAlD
Cinnarizine—CACNA1S—tendon—psoriasis	0.00212	0.0627	CbGeAlD
Cinnarizine—CYP1A1—skin of body—psoriasis	0.000678	0.0201	CbGeAlD
Cinnarizine—CYP2B6—skin of body—psoriasis	0.000659	0.0195	CbGeAlD
Cinnarizine—HRH1—tendon—psoriasis	0.00049	0.0145	CbGeAlD
Cinnarizine—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	0.000181	0.00244	CbGpPWpGaD
Cinnarizine—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	0.000178	0.0024	CbGpPWpGaD
Cinnarizine—CACNA1S—NCAM signaling for neurite out-growth—IL6—psoriasis	0.000177	0.00238	CbGpPWpGaD
Cinnarizine—CACNA1S—Alzheimers Disease—TP53—psoriasis	0.000172	0.00231	CbGpPWpGaD
Cinnarizine—CACNA1I—Axon guidance—TYK2—psoriasis	0.000171	0.00231	CbGpPWpGaD
Cinnarizine—DRD2—G alpha (i) signalling events—CCL20—psoriasis	0.000167	0.00224	CbGpPWpGaD
Cinnarizine—CYP1A1—Melatonin metabolism and effects—NFKB1—psoriasis	0.000166	0.00224	CbGpPWpGaD
Cinnarizine—CACNA1D—Developmental Biology—CARM1—psoriasis	0.000165	0.00222	CbGpPWpGaD
Cinnarizine—HRH1—IL-4 Signaling Pathway—TYK2—psoriasis	0.000164	0.00221	CbGpPWpGaD
Cinnarizine—CYP1A1—Oxidative Stress—NFKB1—psoriasis	0.000162	0.00218	CbGpPWpGaD
Cinnarizine—CACNA1I—Developmental Biology—LEP—psoriasis	0.00016	0.00216	CbGpPWpGaD
Cinnarizine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.00016	0.00215	CbGpPWpGaD
Cinnarizine—CYP1A2—Tryptophan metabolism—CAT—psoriasis	0.000159	0.00214	CbGpPWpGaD
Cinnarizine—CACNA1D—Alzheimers Disease—TNF—psoriasis	0.000158	0.00213	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—NDUFA5—psoriasis	0.000158	0.00212	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—HCAR2—psoriasis	0.000152	0.00205	CbGpPWpGaD
Cinnarizine—HRH4—GPCR downstream signaling—CCL20—psoriasis	0.000147	0.00198	CbGpPWpGaD
Cinnarizine—CACNA1C—Developmental Biology—CARM1—psoriasis	0.000145	0.00195	CbGpPWpGaD
Cinnarizine—CACNA1D—NCAM signaling for neurite out-growth—IL6—psoriasis	0.000144	0.00193	CbGpPWpGaD
Cinnarizine—CACNA1I—Developmental Biology—PPARG—psoriasis	0.00014	0.00188	CbGpPWpGaD
Cinnarizine—CACNA1D—Alzheimers Disease—TP53—psoriasis	0.000139	0.00187	CbGpPWpGaD
Cinnarizine—CACNA1C—Alzheimers Disease—TNF—psoriasis	0.000139	0.00187	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—NDUFA5—psoriasis	0.000139	0.00187	CbGpPWpGaD
Cinnarizine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	0.000138	0.00186	CbGpPWpGaD
Cinnarizine—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	0.000138	0.00186	CbGpPWpGaD
Cinnarizine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000137	0.00184	CbGpPWpGaD
Cinnarizine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	0.000136	0.00183	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—CYP2S1—psoriasis	0.000134	0.00181	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—CCL20—psoriasis	0.000134	0.0018	CbGpPWpGaD
Cinnarizine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.000132	0.00178	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—TAGAP—psoriasis	0.000132	0.00178	CbGpPWpGaD
Cinnarizine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.00013	0.00175	CbGpPWpGaD
Cinnarizine—HRH1—IL-4 Signaling Pathway—NFKB1—psoriasis	0.000128	0.00172	CbGpPWpGaD
Cinnarizine—CACNA1G—Axon guidance—TYK2—psoriasis	0.000126	0.0017	CbGpPWpGaD
Cinnarizine—CACNA1C—NCAM signaling for neurite out-growth—IL6—psoriasis	0.000126	0.0017	CbGpPWpGaD
Cinnarizine—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	0.000125	0.00168	CbGpPWpGaD
Cinnarizine—CACNA1C—Alzheimers Disease—TP53—psoriasis	0.000122	0.00165	CbGpPWpGaD
Cinnarizine—CACNA1H—Axon guidance—TYK2—psoriasis	0.000122	0.00165	CbGpPWpGaD
Cinnarizine—CACNA1I—Developmental Biology—TYK2—psoriasis	0.000122	0.00165	CbGpPWpGaD
Cinnarizine—CACNA1I—Axon guidance—VEGFA—psoriasis	0.000121	0.00163	CbGpPWpGaD
Cinnarizine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	0.000119	0.00161	CbGpPWpGaD
Cinnarizine—CACNA1G—Developmental Biology—LEP—psoriasis	0.000118	0.00159	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—CYP2S1—psoriasis	0.000118	0.00159	CbGpPWpGaD
Cinnarizine—HRH4—G alpha (i) signalling events—CXCL8—psoriasis	0.000116	0.00157	CbGpPWpGaD
Cinnarizine—HRH1—IL-4 Signaling Pathway—STAT3—psoriasis	0.000115	0.00155	CbGpPWpGaD
Cinnarizine—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	0.000115	0.00155	CbGpPWpGaD
Cinnarizine—CACNA1H—Developmental Biology—LEP—psoriasis	0.000114	0.00154	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—HCAR2—psoriasis	0.00011	0.00148	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—HCAR2—psoriasis	0.000108	0.00145	CbGpPWpGaD
Cinnarizine—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	0.000106	0.00143	CbGpPWpGaD
Cinnarizine—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	0.000104	0.0014	CbGpPWpGaD
Cinnarizine—CACNA1S—Axon guidance—TYK2—psoriasis	0.000104	0.0014	CbGpPWpGaD
Cinnarizine—CACNA1G—Developmental Biology—PPARG—psoriasis	0.000103	0.00138	CbGpPWpGaD
Cinnarizine—DRD2—GPCR ligand binding—CCL20—psoriasis	0.000101	0.00136	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—HCAR2—psoriasis	9.96e-05	0.00134	CbGpPWpGaD
Cinnarizine—CACNA1H—Developmental Biology—PPARG—psoriasis	9.96e-05	0.00134	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—CCL20—psoriasis	9.9e-05	0.00133	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—HCAR2—psoriasis	9.78e-05	0.00132	CbGpPWpGaD
Cinnarizine—CACNA1S—Developmental Biology—LEP—psoriasis	9.7e-05	0.00131	CbGpPWpGaD
Cinnarizine—CACNA1I—Developmental Biology—NFKB1—psoriasis	9.53e-05	0.00128	CbGpPWpGaD
Cinnarizine—HRH4—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	9.25e-05	0.00125	CbGpPWpGaD
Cinnarizine—CACNA1G—Developmental Biology—TYK2—psoriasis	9.01e-05	0.00121	CbGpPWpGaD
Cinnarizine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	8.95e-05	0.0012	CbGpPWpGaD
Cinnarizine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriasis	8.95e-05	0.0012	CbGpPWpGaD
Cinnarizine—CACNA1G—Axon guidance—VEGFA—psoriasis	8.93e-05	0.0012	CbGpPWpGaD
Cinnarizine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	8.81e-05	0.00119	CbGpPWpGaD
Cinnarizine—CACNA1H—Developmental Biology—TYK2—psoriasis	8.73e-05	0.00117	CbGpPWpGaD
Cinnarizine—CACNA1H—Axon guidance—VEGFA—psoriasis	8.65e-05	0.00116	CbGpPWpGaD
Cinnarizine—CACNA1I—Developmental Biology—VEGFA—psoriasis	8.65e-05	0.00116	CbGpPWpGaD
Cinnarizine—CACNA1I—Developmental Biology—STAT3—psoriasis	8.56e-05	0.00115	CbGpPWpGaD
Cinnarizine—CACNA1S—Developmental Biology—PPARG—psoriasis	8.45e-05	0.00114	CbGpPWpGaD
Cinnarizine—CACNA1D—Axon guidance—TYK2—psoriasis	8.43e-05	0.00113	CbGpPWpGaD
Cinnarizine—CYP1A1—PPARA activates gene expression—PPARG—psoriasis	8.39e-05	0.00113	CbGpPWpGaD
Cinnarizine—CACNA1I—Axon guidance—IL6—psoriasis	8.38e-05	0.00113	CbGpPWpGaD
Cinnarizine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	8.21e-05	0.0011	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—CCL20—psoriasis	7.91e-05	0.00106	CbGpPWpGaD
Cinnarizine—CACNA1D—Developmental Biology—LEP—psoriasis	7.88e-05	0.00106	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—NDUFA5—psoriasis	7.79e-05	0.00105	CbGpPWpGaD
Cinnarizine—DRD2—Circadian rythm related genes—LEP—psoriasis	7.67e-05	0.00103	CbGpPWpGaD
Cinnarizine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	7.62e-05	0.00103	CbGpPWpGaD
Cinnarizine—CACNA1I—Developmental Biology—TNF—psoriasis	7.41e-05	0.000997	CbGpPWpGaD
Cinnarizine—CACNA1S—Developmental Biology—TYK2—psoriasis	7.41e-05	0.000997	CbGpPWpGaD
Cinnarizine—CACNA1C—Axon guidance—TYK2—psoriasis	7.4e-05	0.000996	CbGpPWpGaD
Cinnarizine—CACNA1S—Axon guidance—VEGFA—psoriasis	7.34e-05	0.000988	CbGpPWpGaD
Cinnarizine—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	7.33e-05	0.000987	CbGpPWpGaD
Cinnarizine—DRD2—Circadian rythm related genes—NOS2—psoriasis	7.15e-05	0.000962	CbGpPWpGaD
Cinnarizine—HRH4—GPCR ligand binding—CXCL8—psoriasis	7.05e-05	0.000948	CbGpPWpGaD
Cinnarizine—CACNA1G—Developmental Biology—NFKB1—psoriasis	7.02e-05	0.000945	CbGpPWpGaD
Cinnarizine—CACNA1C—Developmental Biology—LEP—psoriasis	6.92e-05	0.000932	CbGpPWpGaD
Cinnarizine—CACNA1D—Developmental Biology—PPARG—psoriasis	6.86e-05	0.000923	CbGpPWpGaD
Cinnarizine—CACNA1H—Developmental Biology—NFKB1—psoriasis	6.8e-05	0.000915	CbGpPWpGaD
Cinnarizine—DRD2—Circadian rythm related genes—PPARG—psoriasis	6.68e-05	0.000899	CbGpPWpGaD
Cinnarizine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	6.66e-05	0.000896	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—CYP2S1—psoriasis	6.62e-05	0.000891	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—CARM1—psoriasis	6.56e-05	0.000882	CbGpPWpGaD
Cinnarizine—CACNA1G—Developmental Biology—VEGFA—psoriasis	6.37e-05	0.000858	CbGpPWpGaD
Cinnarizine—CACNA1G—Developmental Biology—STAT3—psoriasis	6.31e-05	0.000849	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—NDUFA5—psoriasis	6.28e-05	0.000846	CbGpPWpGaD
Cinnarizine—CACNA1G—Axon guidance—IL6—psoriasis	6.18e-05	0.000831	CbGpPWpGaD
Cinnarizine—CACNA1H—Developmental Biology—VEGFA—psoriasis	6.17e-05	0.000831	CbGpPWpGaD
Cinnarizine—CACNA1H—Developmental Biology—STAT3—psoriasis	6.11e-05	0.000822	CbGpPWpGaD
Cinnarizine—CACNA1C—Developmental Biology—PPARG—psoriasis	6.03e-05	0.000811	CbGpPWpGaD
Cinnarizine—CACNA1D—Developmental Biology—TYK2—psoriasis	6.01e-05	0.000809	CbGpPWpGaD
Cinnarizine—CACNA1H—Axon guidance—IL6—psoriasis	5.98e-05	0.000805	CbGpPWpGaD
Cinnarizine—CACNA1I—Developmental Biology—IL6—psoriasis	5.98e-05	0.000805	CbGpPWpGaD
Cinnarizine—CACNA1D—Axon guidance—VEGFA—psoriasis	5.96e-05	0.000802	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—HCAR2—psoriasis	5.89e-05	0.000792	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—NDUFA5—psoriasis	5.8e-05	0.000781	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—HCAR2—psoriasis	5.78e-05	0.000778	CbGpPWpGaD
Cinnarizine—CACNA1S—Developmental Biology—NFKB1—psoriasis	5.77e-05	0.000777	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—CARM1—psoriasis	5.76e-05	0.000775	CbGpPWpGaD
Cinnarizine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	5.7e-05	0.000768	CbGpPWpGaD
Cinnarizine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	5.7e-05	0.000768	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—CCL20—psoriasis	5.7e-05	0.000767	CbGpPWpGaD
Cinnarizine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	5.66e-05	0.000761	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—CCL20—psoriasis	5.6e-05	0.000753	CbGpPWpGaD
Cinnarizine—CACNA1G—Developmental Biology—TNF—psoriasis	5.46e-05	0.000735	CbGpPWpGaD
Cinnarizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	5.45e-05	0.000733	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.41e-05	0.000728	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—CYP2S1—psoriasis	5.34e-05	0.000719	CbGpPWpGaD
Cinnarizine—CACNA1H—Developmental Biology—TNF—psoriasis	5.29e-05	0.000712	CbGpPWpGaD
Cinnarizine—CACNA1C—Developmental Biology—TYK2—psoriasis	5.28e-05	0.000711	CbGpPWpGaD
Cinnarizine—CACNA1S—Developmental Biology—VEGFA—psoriasis	5.24e-05	0.000705	CbGpPWpGaD
Cinnarizine—CACNA1C—Axon guidance—VEGFA—psoriasis	5.24e-05	0.000705	CbGpPWpGaD
Cinnarizine—CACNA1S—Developmental Biology—STAT3—psoriasis	5.19e-05	0.000698	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—CCL20—psoriasis	5.18e-05	0.000696	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—TAGAP—psoriasis	5.1e-05	0.000687	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—CCL20—psoriasis	5.08e-05	0.000684	CbGpPWpGaD
Cinnarizine—CACNA1S—Axon guidance—IL6—psoriasis	5.08e-05	0.000683	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—TAGAP—psoriasis	5.01e-05	0.000674	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—CYP2S1—psoriasis	4.93e-05	0.000664	CbGpPWpGaD
Cinnarizine—DRD2—Circadian rythm related genes—JUN—psoriasis	4.74e-05	0.000638	CbGpPWpGaD
Cinnarizine—CACNA1D—Developmental Biology—NFKB1—psoriasis	4.69e-05	0.00063	CbGpPWpGaD
Cinnarizine—DRD2—G alpha (i) signalling events—CXCL8—psoriasis	4.5e-05	0.000605	CbGpPWpGaD
Cinnarizine—CACNA1S—Developmental Biology—TNF—psoriasis	4.49e-05	0.000604	CbGpPWpGaD
Cinnarizine—CACNA1G—Developmental Biology—IL6—psoriasis	4.41e-05	0.000593	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—NDUFA5—psoriasis	4.37e-05	0.000588	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—SOCS1—psoriasis	4.36e-05	0.000586	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—NDUFA5—psoriasis	4.33e-05	0.000583	CbGpPWpGaD
Cinnarizine—CACNA1H—Developmental Biology—IL6—psoriasis	4.27e-05	0.000574	CbGpPWpGaD
Cinnarizine—CACNA1D—Developmental Biology—VEGFA—psoriasis	4.25e-05	0.000572	CbGpPWpGaD
Cinnarizine—CACNA1D—Developmental Biology—STAT3—psoriasis	4.21e-05	0.000567	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—TYK2—psoriasis	4.15e-05	0.000559	CbGpPWpGaD
Cinnarizine—CACNA1D—Axon guidance—IL6—psoriasis	4.12e-05	0.000555	CbGpPWpGaD
Cinnarizine—CACNA1C—Developmental Biology—NFKB1—psoriasis	4.12e-05	0.000554	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.04e-05	0.000543	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—CAT—psoriasis	4.03e-05	0.000543	CbGpPWpGaD
Cinnarizine—HRH4—GPCR downstream signaling—CXCL8—psoriasis	3.98e-05	0.000536	CbGpPWpGaD
Cinnarizine—CACNA1C—Developmental Biology—VEGFA—psoriasis	3.74e-05	0.000503	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—CYP2S1—psoriasis	3.71e-05	0.0005	CbGpPWpGaD
Cinnarizine—CACNA1C—Developmental Biology—STAT3—psoriasis	3.7e-05	0.000498	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—NDUFA5—psoriasis	3.7e-05	0.000498	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—CYP2S1—psoriasis	3.68e-05	0.000495	CbGpPWpGaD
Cinnarizine—CACNA1D—Developmental Biology—TNF—psoriasis	3.64e-05	0.00049	CbGpPWpGaD
Cinnarizine—CACNA1S—Developmental Biology—IL6—psoriasis	3.62e-05	0.000487	CbGpPWpGaD
Cinnarizine—CACNA1C—Axon guidance—IL6—psoriasis	3.62e-05	0.000487	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—CXCL8—psoriasis	3.62e-05	0.000487	CbGpPWpGaD
Cinnarizine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	3.58e-05	0.000481	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—CAT—psoriasis	3.54e-05	0.000477	CbGpPWpGaD
Cinnarizine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	3.51e-05	0.000472	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.45e-05	0.000464	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—CARM1—psoriasis	3.23e-05	0.000435	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—LEP—psoriasis	3.21e-05	0.000433	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—APOE—psoriasis	3.21e-05	0.000433	CbGpPWpGaD
Cinnarizine—CACNA1C—Developmental Biology—TNF—psoriasis	3.2e-05	0.000431	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—CYP2S1—psoriasis	3.15e-05	0.000423	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—APOE—psoriasis	3.13e-05	0.000422	CbGpPWpGaD
Cinnarizine—DRD2—Circadian rythm related genes—TP53—psoriasis	3.13e-05	0.000421	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—CCL20—psoriasis	3.06e-05	0.000411	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—CCL20—psoriasis	3e-05	0.000404	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—NFKBIA—psoriasis	3e-05	0.000403	CbGpPWpGaD
Cinnarizine—CACNA1D—Developmental Biology—IL6—psoriasis	2.94e-05	0.000396	CbGpPWpGaD
Cinnarizine—DRD2—Circadian rythm related genes—IL6—psoriasis	2.86e-05	0.000385	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—APOE—psoriasis	2.75e-05	0.000371	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—PPARG—psoriasis	2.73e-05	0.000367	CbGpPWpGaD
Cinnarizine—DRD2—GPCR ligand binding—CXCL8—psoriasis	2.72e-05	0.000366	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—CXCL8—psoriasis	2.67e-05	0.00036	CbGpPWpGaD
Cinnarizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	2.66e-05	0.000358	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—CARM1—psoriasis	2.61e-05	0.000351	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.59e-05	0.000348	CbGpPWpGaD
Cinnarizine—CACNA1C—Developmental Biology—IL6—psoriasis	2.58e-05	0.000348	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—TYK2—psoriasis	2.45e-05	0.00033	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—CARM1—psoriasis	2.41e-05	0.000324	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—PPARG—psoriasis	2.4e-05	0.000323	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.25e-05	0.000303	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—CXCL8—psoriasis	2.14e-05	0.000287	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—IL6—psoriasis	2.03e-05	0.000273	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—CAT—psoriasis	1.99e-05	0.000268	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—JUN—psoriasis	1.99e-05	0.000267	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.93e-05	0.00026	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—NFKB1—psoriasis	1.91e-05	0.000257	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—CARM1—psoriasis	1.81e-05	0.000244	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—CARM1—psoriasis	1.8e-05	0.000242	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—VEGFA—psoriasis	1.73e-05	0.000233	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—STAT3—psoriasis	1.72e-05	0.000231	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—SOCS1—psoriasis	1.68e-05	0.000227	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.68e-05	0.000226	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—SOCS1—psoriasis	1.65e-05	0.000222	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.65e-05	0.000222	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—TYK2—psoriasis	1.61e-05	0.000216	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—CAT—psoriasis	1.6e-05	0.000216	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—TYK2—psoriasis	1.58e-05	0.000212	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—APOE—psoriasis	1.55e-05	0.000208	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—CXCL8—psoriasis	1.54e-05	0.000207	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—CARM1—psoriasis	1.54e-05	0.000207	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—CXCL8—psoriasis	1.51e-05	0.000203	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—CAT—psoriasis	1.48e-05	0.000199	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.44e-05	0.000193	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—CXCL8—psoriasis	1.4e-05	0.000188	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—CXCL8—psoriasis	1.37e-05	0.000185	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—PPARG—psoriasis	1.35e-05	0.000181	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—TP53—psoriasis	1.31e-05	0.000176	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—APOE—psoriasis	1.25e-05	0.000168	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—LEP—psoriasis	1.24e-05	0.000167	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—APOE—psoriasis	1.24e-05	0.000167	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—APOE—psoriasis	1.22e-05	0.000164	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—LEP—psoriasis	1.22e-05	0.000164	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—IL6—psoriasis	1.2e-05	0.000161	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—NFKBIA—psoriasis	1.16e-05	0.000156	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—APOE—psoriasis	1.15e-05	0.000155	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—NFKBIA—psoriasis	1.14e-05	0.000153	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—CAT—psoriasis	1.12e-05	0.00015	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—CAT—psoriasis	1.11e-05	0.000149	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—PPARG—psoriasis	1.09e-05	0.000146	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—PPARG—psoriasis	1e-05	0.000135	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—TYK2—psoriasis	9.48e-06	0.000128	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—CAT—psoriasis	9.45e-06	0.000127	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—TYK2—psoriasis	9.31e-06	0.000125	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—APOE—psoriasis	8.67e-06	0.000117	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—APOE—psoriasis	8.59e-06	0.000116	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—CXCL8—psoriasis	8.26e-06	0.000111	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—CXCL8—psoriasis	8.11e-06	0.000109	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—IL6—psoriasis	7.85e-06	0.000106	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—IL6—psoriasis	7.71e-06	0.000104	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—JUN—psoriasis	7.68e-06	0.000103	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—PPARG—psoriasis	7.55e-06	0.000102	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—JUN—psoriasis	7.54e-06	0.000101	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—PPARG—psoriasis	7.48e-06	0.000101	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—NFKB1—psoriasis	7.39e-06	9.94e-05	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—APOE—psoriasis	7.34e-06	9.88e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—NFKB1—psoriasis	7.25e-06	9.76e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—VEGFA—psoriasis	6.71e-06	9.02e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—STAT3—psoriasis	6.64e-06	8.93e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—VEGFA—psoriasis	6.58e-06	8.86e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—STAT3—psoriasis	6.52e-06	8.77e-05	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—PPARG—psoriasis	6.4e-06	8.61e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—TP53—psoriasis	5.07e-06	6.82e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—TP53—psoriasis	4.97e-06	6.69e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—IL6—psoriasis	4.64e-06	6.24e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—IL6—psoriasis	4.55e-06	6.13e-05	CbGpPWpGaD
